Standout Papers
- Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study (2022)
- Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects (2022)
Immediate Impact
3 from Science/Nature 36 standout
Citing Papers
Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors
2025 StandoutNature
From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine
2025 Standout
Works of Friederike Holze being referenced
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
2020
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Friederike Holze | 1638 | 1080 | 952 | 44 | 1.8k | |
| Patrick C. Dolder | 1941 | 1033 | 1222 | 43 | 2.3k | |
| Natasha L. Mason | 1674 | 939 | 938 | 68 | 2.0k | |
| Felix Hasler | 1229 | 702 | 754 | 28 | 1.8k | |
| Christopher Timmermann | 1855 | 1014 | 891 | 59 | 2.2k | |
| Torsten Passie | 1892 | 1031 | 1009 | 45 | 2.5k | |
| Peter Gasser | 1411 | 900 | 738 | 16 | 1.5k | |
| Sarah E. Mennenga | 1397 | 940 | 636 | 28 | 1.9k | |
| Hannes Kettner | 1444 | 853 | 596 | 50 | 1.7k | |
| Michael Kometer | 2260 | 1133 | 1458 | 37 | 2.9k | |
| Nathan D. Sepeda | 1484 | 947 | 774 | 17 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...